4.8 Review

Senescent cells and osteoarthritis: a painful connection

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 128, Issue 4, Pages 1229-1237

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI95147

Keywords

-

Funding

  1. Unity Biotechnology
  2. Morton Goldberg Chair
  3. Bloombergsimilar toKimmel Institute for Cancer Immunotherapy
  4. NIH [AG009909]
  5. Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-17-1-0627]
  6. NATIONAL INSTITUTE ON AGING [R37AG009909, R56AG009909] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Senescent cells (SnCs) are associated with age-related pathologies. Osteoarthritis is a chronic disease characterized by pain, loss of cartilage, and joint inflammation, and its incidence increases with age. For years, the presence of SnCs in cartilage isolated from patients undergoing total knee artificial implants has been noted, but these cells' relevance to disease was unclear. In this Review, we summarize current knowledge of SnCs in the multiple tissues that constitute the articular joint. New evidence for the causative role of SnCs in the development of posttraumatic and age-related arthritis is reviewed along with the therapeutic benefit of SnC clearance. As part of their senescence-associated secretory phenotype, SnCs secrete cytokines that impact the immune system and its response to joint tissue trauma. We present concepts of the immune response to tissue trauma as well as the interactions with SnCs and the local tissue environment. Finally, we discuss therapeutic implications of targeting SnCs in treating osteoarthritis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available